SynoJoynt 1% Sodium Hyaluronate, 3 Dose

Finished Product

82197-0721-16

Human

Orthobiologics

Product

SynoJoynt® is a high molecular weight, non-crosslinked sodium hyaluronate derived from bacterial fermentation with excellent safety and tolerability.1 It is indicated for the treatment of pain from osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics.
Explore the new
<a href="https://engage.arthrex.com/synojoynt-resource-kit" target="_blank" rel="noopener noreferrer" class="btn btn-outline-light mb-3">SynoJoynt® Resource Kit</a>
Reference:
1. US Food and Drug Administration. Summary of safety and effectiveness (SSED) for SynoJoynt. Accessed January 5, 2022. <a href="https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170016B.pdf">https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170016B.pdf</a>
INDICATIONS
SYNOJOYNT is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).
CONTRAINDICATIONS
<ul>
 <li>Do not use SYNOJOYNT to treat patients who have a known hypersensitivity to hyaluronan preparations.</li>
 <li>Do not use to treat patients with knee joint infections or to treat patients with infections or skin disease in the area of the injection site.</li>
</ul>
WARNINGS
<ul>
 <li>Do not concomitantly use disinfectants containing quaternary ammonium salts or chlorhexidine for skin preparations because hyaluronan can precipitate in their presence.</li>
 <li>Do not inject intravascularly because intravascular injections of SYNOJOYNT may cause systemic adverse events.</li>
</ul>

SynoJoynt 1% Sodium Hyaluronate, 3 Dose

82197-0721-16

Related Pages

Orthobiologics

SynoJoynt® 1% Sodium Hyaluronate

Product